A new study from La Trobe University has identified significant gaps in HIV testing, diagnosis and prevention that are ...

A recombinant zoster vaccine builds strong antibody protection in people living with HIV, regardless of their CD4 count — but their cellular immune response still lags behind those without HIV.

Global efforts to prevent HIV lost ground last year as funding disruptions forced countries to scale back services, even as ...

There is no cure for HIV. While scientists have made considerable progress in controlling the infection, patients still must ...

Women living with HIV for 15 years or longer show heightened depression and self-silencing during the COVID pandemic, with the link to depression being stronger among those with prior COVID.

The collaboration enables 14 countries to access lenacapavir for PrEP outside of Gilead’s current voluntary licensing ...

Unchecked infection accelerates proteomic aging in HIV, but prompt suppressive therapy can reverse biological decay. Read ...